PharmacotherapeuticsuiforuiAdvanceduiPracticeuiNurseuiPrescribersui5thuiEditionuiWoouiRobinson
uiTestuiBank
, PharmacotherapeuticsuiforuiAdvanceduiPracticeuiNurseuiPrescribersui5thuiEditionuiWoouiRobinson
uiTestuiBank
Pharmacotherapeutics ui
foruiAdvanceduiPracticeuiNurseuiPrescribersui5thuiEditionuiWoouiRobinsonuiTestuiBank
Chapterui1.uiTheuiRoleuiofuitheuiNurseuiPractiti
oneruiMultipleuiChoice
Identifyuitheuichoiceuithatuibestuicompletesuitheuistatementuioruianswersuitheuiquestion.
ui uiui 1.uiNurseuipractitioneruiprescriptiveuiauthorityuiisuiregulatedui by:
1. TheuiNationaluiCounciluiofuiStateuiBoardsuiofuiNursing
2. TheuiU.S.uiDruguiEnforcementuiAdministration
3. TheuiStateuiBoarduiofuiNursinguiforuieachuistate
4. TheuiStateuiBoarduiofuiPharmacy
ui
uiui 2.uiTheuibenefitsuitouitheuipatientuiofuihavinguianuiAdvanceduiPracticeuiRegistereduiNurseui(A
PRN)uiprescriberuiinclude:
1. NursesuiknowuimoreuiaboutuiPharmacologyuithanuiotheruiprescribersuibecauseuitheyu
itakeuiitub
i othuiinuitheiruibasicuinursinguiprogramuianduiinuitheiruiAPRNuiprogram.
2. Nursesuicareuiforuitheuipatientuifromuiauiholisticuiapproachuianduiincludeuitheuipatientuiin
decisionuimakinguiregardinguitheiruicare.
3. APRNsuiareuilessuilikelyuitouiprescribeuinarcoticsuianduiotheruicontrolleduisubstances.
4. APRNsuiareuiableuitouiprescribeuiindependentlyuiinuialluistates,uiwhereasuiauiphy
sician’suiassistantuineedsuitouihaveuiauiphysicianuisupervisinguitheiruipractice.
ui uiui 3.uiClinicaluijudgmentuiinuiprescribingui includes:
1. Factoringuiinuitheuicostuitouitheuipatientuiofuitheuimedicationuiprescribed
2. Alwaysuiprescribinguitheuinewestuimedicationuiavailableuiforuitheuidiseaseuiprocess
3. Handinguioutuidruguisamplesuitouipooruipatients
4. Prescribinguialluigenericuimedicationsuitouicutuicosts
ui uiui 4.uiCriteriauiforuichoosinguianuieffectiveuidruguiforuiauidisorderui include:
1. Askinguitheuipatientuiwhatuidruguitheyuithinkuiwoulduiworkuibestuiforuithem
2. Consultinguinationallyuirecognizeduiguidelinesuiforuidiseaseuimanagement
3. Prescribinguimedicationsuithatuiareuiavailableuiasuisamplesuibeforeuiwritinguiauiprescription
4. FollowinguiU.S.uiDruguiEnforcementuiAdministrationuiguidelinesuiforuiprescribing
ui uiui 5.uiNurseuipractitioneruipracticeuimayuithriveuiunderuihealth-careuireformuibecauseui of:
1. Theuidemonstrateduiabilityuiofuinurseuipractitionersuitouicontroluicostsuianduiimproveu
ipatientuo
i utcomes
2. Theuifactuithatuinurseuipractitionersuiwilluibeuiableuitouipracticeuiindependently
3. Theuifactuithatuinurseuipractitionersuiwilluihaveuifulluireimbursementuiunderuiheal
th-careuireform
4. TheuiabilityuitouishiftuiaccountabilityuiforuiMedicaiduitouitheuistateuilevel
,PharmacotherapeuticsuiforuiAdvanceduiPracticeuiNurseuiPrescribersui5thuiEditionuiWoouiRobinson
uiTestuiBank
, PharmacotherapeuticsuiforuiAdvanceduiPracticeuiNurseuiPrescribersui5thuiEditionuiWoouiRobinson
uiTestuiBank
Chapterui1.uiTheuiRoleuiofuitheuiNurseuiPractiti
oneruiAnsweruiSection
MULTIPLEuiCHOICE
1. ANS:uiuiui 3 PTS:u i 1
2. ANS:uiuiui 2 PTS:u i 1
3. ANS:uiuiui 1 PTS:u i 1
4. ANS:uiuiui 2 PTS:u i 1
5. ANS:uiuiui 1 PTS:u i 1
Chapterui2.uiReviewuiofuiBasicuiPrinciplesuiofuiPharmac
ologyuM
i ultipleuiChoice
Identifyuitheuichoiceuithatuibestuicompletesuitheuistatementuioruianswersuitheuiquestion.
ui
uiui 1.uiAuipatient’suinutritionaluiintakeuianduilaboratoryuiresultsuireflectuihypoalbuminemia.uiTh
isuiisuicriticaluitoupi rescribinguibecause:
1. Distributionuiofuidrugsuitouitargetuitissueuimayuibeuiaffected.
2. Theuisolubilityuiofuitheuidruguiwilluinotuimatchuitheuisiteuiofuiabsorption.
3. Thereuiwilluibeuilessuifreeuidruguiavailableuitouigenerateuianuieffect.
4. Drugsuibounduitouialbuminuiareuireadilyuiexcreteduibyuitheuikidneys.
ui uiui 2.uiDrugsuithatuihaveuiauisignificantuifirst-passui effect:
1. Mustuibeuigivenuibyuitheuienteralui(oral)uirouteuionly
2. Bypassuitheuihepaticuicirculation
3. Areuirapidlyuimetabolizeduibyuitheuiliveruianduimayuihaveuilittleuiifuianyuidesireduiaction
4. Areuiconverteduibyuitheuiliveruitouimoreuiactiveuianduifat-solubleuiforms
ui uiui 3.uiTheuirouteuiofuiexcretionuiofuiauivolatileuidruguiwilluilikelyuibeui the:
1. Kidneys
2. Lungs
3. Bileuianduifeces
4. Skin
ui
uiui 4.uiMedroxyprogesteroneui(DepouiProvera)uiisuiprescribeduiintramuscularlyui(IM)uitouicr
eateuiauistorageuireservoiruiofuitheuidrug.uiStorageuireservoirs:
1. Assureuithatuitheuidruguiwilluireachuiitsuiintendeduitargetuitissue
2. Areuitheuireasonuiforuigivinguiloadinguidoses
3. Increaseuitheuilengthuiofuitimeuiauidruguiisuiavailableuianduiactive
4. Areuimostuicommonuiinuicollagenuitissues
ui uiui 5.uiTheuiNPuichoosesuitouigiveuicephalexinuieveryui8uihoursuibaseduionuiknowledgeuiofuitheuidrug’s:
1. Propensityuitouigouitouitheuitargetuireceptor
2. Biologicaluihalf-life
3. Pharmacodynamics
4. Safetyuianduisideuieffects
uiTestuiBank
, PharmacotherapeuticsuiforuiAdvanceduiPracticeuiNurseuiPrescribersui5thuiEditionuiWoouiRobinson
uiTestuiBank
Pharmacotherapeutics ui
foruiAdvanceduiPracticeuiNurseuiPrescribersui5thuiEditionuiWoouiRobinsonuiTestuiBank
Chapterui1.uiTheuiRoleuiofuitheuiNurseuiPractiti
oneruiMultipleuiChoice
Identifyuitheuichoiceuithatuibestuicompletesuitheuistatementuioruianswersuitheuiquestion.
ui uiui 1.uiNurseuipractitioneruiprescriptiveuiauthorityuiisuiregulatedui by:
1. TheuiNationaluiCounciluiofuiStateuiBoardsuiofuiNursing
2. TheuiU.S.uiDruguiEnforcementuiAdministration
3. TheuiStateuiBoarduiofuiNursinguiforuieachuistate
4. TheuiStateuiBoarduiofuiPharmacy
ui
uiui 2.uiTheuibenefitsuitouitheuipatientuiofuihavinguianuiAdvanceduiPracticeuiRegistereduiNurseui(A
PRN)uiprescriberuiinclude:
1. NursesuiknowuimoreuiaboutuiPharmacologyuithanuiotheruiprescribersuibecauseuitheyu
itakeuiitub
i othuiinuitheiruibasicuinursinguiprogramuianduiinuitheiruiAPRNuiprogram.
2. Nursesuicareuiforuitheuipatientuifromuiauiholisticuiapproachuianduiincludeuitheuipatientuiin
decisionuimakinguiregardinguitheiruicare.
3. APRNsuiareuilessuilikelyuitouiprescribeuinarcoticsuianduiotheruicontrolleduisubstances.
4. APRNsuiareuiableuitouiprescribeuiindependentlyuiinuialluistates,uiwhereasuiauiphy
sician’suiassistantuineedsuitouihaveuiauiphysicianuisupervisinguitheiruipractice.
ui uiui 3.uiClinicaluijudgmentuiinuiprescribingui includes:
1. Factoringuiinuitheuicostuitouitheuipatientuiofuitheuimedicationuiprescribed
2. Alwaysuiprescribinguitheuinewestuimedicationuiavailableuiforuitheuidiseaseuiprocess
3. Handinguioutuidruguisamplesuitouipooruipatients
4. Prescribinguialluigenericuimedicationsuitouicutuicosts
ui uiui 4.uiCriteriauiforuichoosinguianuieffectiveuidruguiforuiauidisorderui include:
1. Askinguitheuipatientuiwhatuidruguitheyuithinkuiwoulduiworkuibestuiforuithem
2. Consultinguinationallyuirecognizeduiguidelinesuiforuidiseaseuimanagement
3. Prescribinguimedicationsuithatuiareuiavailableuiasuisamplesuibeforeuiwritinguiauiprescription
4. FollowinguiU.S.uiDruguiEnforcementuiAdministrationuiguidelinesuiforuiprescribing
ui uiui 5.uiNurseuipractitioneruipracticeuimayuithriveuiunderuihealth-careuireformuibecauseui of:
1. Theuidemonstrateduiabilityuiofuinurseuipractitionersuitouicontroluicostsuianduiimproveu
ipatientuo
i utcomes
2. Theuifactuithatuinurseuipractitionersuiwilluibeuiableuitouipracticeuiindependently
3. Theuifactuithatuinurseuipractitionersuiwilluihaveuifulluireimbursementuiunderuiheal
th-careuireform
4. TheuiabilityuitouishiftuiaccountabilityuiforuiMedicaiduitouitheuistateuilevel
,PharmacotherapeuticsuiforuiAdvanceduiPracticeuiNurseuiPrescribersui5thuiEditionuiWoouiRobinson
uiTestuiBank
, PharmacotherapeuticsuiforuiAdvanceduiPracticeuiNurseuiPrescribersui5thuiEditionuiWoouiRobinson
uiTestuiBank
Chapterui1.uiTheuiRoleuiofuitheuiNurseuiPractiti
oneruiAnsweruiSection
MULTIPLEuiCHOICE
1. ANS:uiuiui 3 PTS:u i 1
2. ANS:uiuiui 2 PTS:u i 1
3. ANS:uiuiui 1 PTS:u i 1
4. ANS:uiuiui 2 PTS:u i 1
5. ANS:uiuiui 1 PTS:u i 1
Chapterui2.uiReviewuiofuiBasicuiPrinciplesuiofuiPharmac
ologyuM
i ultipleuiChoice
Identifyuitheuichoiceuithatuibestuicompletesuitheuistatementuioruianswersuitheuiquestion.
ui
uiui 1.uiAuipatient’suinutritionaluiintakeuianduilaboratoryuiresultsuireflectuihypoalbuminemia.uiTh
isuiisuicriticaluitoupi rescribinguibecause:
1. Distributionuiofuidrugsuitouitargetuitissueuimayuibeuiaffected.
2. Theuisolubilityuiofuitheuidruguiwilluinotuimatchuitheuisiteuiofuiabsorption.
3. Thereuiwilluibeuilessuifreeuidruguiavailableuitouigenerateuianuieffect.
4. Drugsuibounduitouialbuminuiareuireadilyuiexcreteduibyuitheuikidneys.
ui uiui 2.uiDrugsuithatuihaveuiauisignificantuifirst-passui effect:
1. Mustuibeuigivenuibyuitheuienteralui(oral)uirouteuionly
2. Bypassuitheuihepaticuicirculation
3. Areuirapidlyuimetabolizeduibyuitheuiliveruianduimayuihaveuilittleuiifuianyuidesireduiaction
4. Areuiconverteduibyuitheuiliveruitouimoreuiactiveuianduifat-solubleuiforms
ui uiui 3.uiTheuirouteuiofuiexcretionuiofuiauivolatileuidruguiwilluilikelyuibeui the:
1. Kidneys
2. Lungs
3. Bileuianduifeces
4. Skin
ui
uiui 4.uiMedroxyprogesteroneui(DepouiProvera)uiisuiprescribeduiintramuscularlyui(IM)uitouicr
eateuiauistorageuireservoiruiofuitheuidrug.uiStorageuireservoirs:
1. Assureuithatuitheuidruguiwilluireachuiitsuiintendeduitargetuitissue
2. Areuitheuireasonuiforuigivinguiloadinguidoses
3. Increaseuitheuilengthuiofuitimeuiauidruguiisuiavailableuianduiactive
4. Areuimostuicommonuiinuicollagenuitissues
ui uiui 5.uiTheuiNPuichoosesuitouigiveuicephalexinuieveryui8uihoursuibaseduionuiknowledgeuiofuitheuidrug’s:
1. Propensityuitouigouitouitheuitargetuireceptor
2. Biologicaluihalf-life
3. Pharmacodynamics
4. Safetyuianduisideuieffects
